Perez-Corredor P, Vanderleest T, Vacano G, Sanchez J, Villalba-Moreno N, Marino C
Front Mol Neurosci. 2024; 17:1373568.
PMID: 38571814
PMC: 10987717.
DOI: 10.3389/fnmol.2024.1373568.
Qu J, Chakir K, Tarasov K, Riordon D, Perino M, Silvester A
Elife. 2024; 12.
PMID: 38251682
PMC: 10945681.
DOI: 10.7554/eLife.88732.
Gonzalez Suarez N, Fernandez-Marrero Y, Hebert M, Roy M, Boudreau L, Annabi B
Cancer Cell Int. 2023; 23(1):240.
PMID: 37833751
PMC: 10576371.
DOI: 10.1186/s12935-023-03087-2.
Umbarkar P, Ruiz Ramirez S, Toro Cora A, Tousif S, Lal H
Biochim Biophys Acta Mol Basis Dis. 2023; 1869(6):166724.
PMID: 37094727
PMC: 10247467.
DOI: 10.1016/j.bbadis.2023.166724.
Lee Y, Yoon S, Hong H, Kim H, Jung D, Moon B
Molecules. 2022; 27(12).
PMID: 35744952
PMC: 9230645.
DOI: 10.3390/molecules27123825.
Tau Acts in Concert With Kinase/Phosphatase Underlying Synaptic Dysfunction.
Fan X, Xia L, Zhou Z, Qiu Y, Zhao C, Yin X
Front Aging Neurosci. 2022; 14:908881.
PMID: 35711910
PMC: 9196307.
DOI: 10.3389/fnagi.2022.908881.
Role of Glycogen Synthase Kinase-3 in Interferon-γ-Mediated Immune Hepatitis.
Chen C, Tseng P, Satria R, Nguyen T, Tsai C, Lin C
Int J Mol Sci. 2022; 23(9).
PMID: 35563060
PMC: 9101719.
DOI: 10.3390/ijms23094669.
Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Brody A, Nies S, Guan F, Smith L, Mukherjee B, Salazar S
Mol Neurodegener. 2022; 17(1):32.
PMID: 35501917
PMC: 9063299.
DOI: 10.1186/s13024-022-00526-y.
Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.
Marosi M, Arman P, Aceto G, DAscenzo M, Laezza F
Int J Mol Sci. 2022; 23(8).
PMID: 35457230
PMC: 9028019.
DOI: 10.3390/ijms23084413.
GSK-3β Localizes to the Cardiac Z-Disc to Maintain Length Dependent Activation.
Stachowski-Doll M, Papadaki M, Martin T, Ma W, Gong H, Shao S
Circ Res. 2022; 130(6):871-886.
PMID: 35168370
PMC: 8930626.
DOI: 10.1161/CIRCRESAHA.121.319491.
GSK-3 and Tau: A Key Duet in Alzheimer's Disease.
Sayas C, Avila J
Cells. 2021; 10(4).
PMID: 33804962
PMC: 8063930.
DOI: 10.3390/cells10040721.
Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
He R, Du S, Lei T, Xie X, Wang Y
Oncol Rep. 2020; 44(6):2373-2385.
PMID: 33125126
PMC: 7610307.
DOI: 10.3892/or.2020.7817.
Glycogen Synthase Kinase-3β Facilitates Cytokine Production in 12-O-Tetradecanoylphorbol-13-Acetate/Ionomycin-Activated Human CD4 T Lymphocytes.
Tsai C, Tsai C, Tseng P, Lin C, Chen C
Cells. 2020; 9(6).
PMID: 32521784
PMC: 7348852.
DOI: 10.3390/cells9061424.
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.
Timchenko L
Int J Mol Sci. 2019; 21(1).
PMID: 31877772
PMC: 6982105.
DOI: 10.3390/ijms21010094.
Pyk2 Signaling through Graf1 and RhoA GTPase Is Required for Amyloid-β Oligomer-Triggered Synapse Loss.
Lee S, Salazar S, Cox T, Strittmatter S
J Neurosci. 2019; 39(10):1910-1929.
PMID: 30626696
PMC: 6407289.
DOI: 10.1523/JNEUROSCI.2983-18.2018.
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss.
Salazar S, Cox T, Lee S, Brody A, Chyung A, Haas L
J Neurosci. 2018; 39(4):758-772.
PMID: 30518596
PMC: 6343652.
DOI: 10.1523/JNEUROSCI.1873-18.2018.
PYK2 negatively regulates the Hippo pathway in TNBC by stabilizing TAZ protein.
Kedan A, Verma N, Saroha A, Shreberk-Shaked M, Muller A, Nair N
Cell Death Dis. 2018; 9(10):985.
PMID: 30250159
PMC: 6155151.
DOI: 10.1038/s41419-018-1005-z.
Glycogen synthase kinase 3 controls migration of the neural crest lineage in mouse and Xenopus.
Gonzalez Malagon S, Munoz A, Doro D, Bolger T, Poon E, Tucker E
Nat Commun. 2018; 9(1):1126.
PMID: 29555900
PMC: 5859133.
DOI: 10.1038/s41467-018-03512-5.
Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
Brody A, Strittmatter S
Adv Pharmacol. 2018; 82:293-323.
PMID: 29413525
PMC: 5835229.
DOI: 10.1016/bs.apha.2017.09.007.
Glycogen synthase kinase-3: a potential preventive target for prostate cancer management.
Li B, Thrasher J, Terranova P
Urol Oncol. 2015; 33(11):456-63.
PMID: 26051358
PMC: 4753786.
DOI: 10.1016/j.urolonc.2015.05.006.